AzTrials
AzTrials

Pathological GamblingPhase 2NCT00337753

Cognitive Behavioral Therapy for Pathological Gambling

A Phase 2 study testing Cognitive Behavioral Therapy and Wait-list in people with Pathological Gambling, run by University of Minnesota at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of the study is to evaluate a new form of counseling for pathological gambling and to see if the counseling is more effective than attending Gamblers Anonymous. Read more about this study

Who is it for?
Ages 18 to 75 years
Conditions the study is for
Pathological Gambling
What is being tested?
Cognitive Behavioral Therapy and Wait-list
Could I receive a placebo?
No, everyone receives an active treatment
How many people
76 participants
Where
1 siteUnited States
Study dates
Jun 2006to Jun 2009
Phase
Phase 2
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 75 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Outpatient men and women age 18 to 75
  • Presence of current DSM-IV pathological gambling for at least 6 months duration
  • PG is the most problematic psychiatric disorder (in the patient's and clinician's opinion) and the primary reason for seeking treatment
  • Minimum score of >5 on the South Oaks Gambling Screen which reflects gambling severity consistent with pathological gambling

Who cannot join

  • Current clinically significant suicidality, severe depression (a score of ≥ 19 on the Hamilton Rating Scale for Depression, 17-item version)(30) or any other disorder requiring immediate intervention
  • Presence of any clinical features requiring a higher level of care than outpatient treatment
  • Cognitive impairment that interferes with the capacity to engage in CBT or to provide informed consent
  • DSM-IV substance abuse or dependence within the past 3 months (see Screening Visit)
  • Current Axis I diagnosis of bipolar disorder or psychotic disorder
  • Previous treatment of CBT for PG (duration of at least 6 sessions); because CBT is not widely used for PG, a minimum of 6 treatments will be rare.
  • Current use of psychotropic medications or within 2 months prior to study entry.
  • Current participation in Gambler's Anonymous (GA).

Trial locations and contacts

1 site in 1 country.

United States1 site
  • University of Minnesota Medical Center

    Minneapolis, Minnesota, 55454

Other trials in United States

About this study

The purpose of the study is to evaluate a new form of counseling for pathological gambling and to see if the counseling is more effective than attending Gamblers Anonymous.

Read the detailed description

Subjects will be assigned to counseling or be given a referral list of available Gamblers Anonymous meetings at the first visit based on answers to questions. Assignment to counseling or Gamblers Anonymous will be randomly selected (i.e. chance) with an equal chance of receiving either one. For those assigned to counseling, you will meet with the therapist for 60 minutes weekly. You will receive 5 sessions of counseling.

All subjects will be assessed with gambling questionnaires twice during the 5-week period and again at 3 and 6 months following the 5-week period.

For those assigned to Gamblers Anonymous, they will be offered 5 weeks of counseling at the end of the 6-month follow-up.

Being tested
Cognitive Behavioral Therapy, Wait-list
Keywords
Gambling
Medical subject headings
Gambling

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Cognitive Behavioral TherapyBehavioural

    Also called CBT

    5-weeks of Cognitive Behavioral Therapy

  • Wait-listBehavioural

    subjects assigned to wait-list condition for six-weeks

Study groups in NCT00337753
Study groupRoleWhat they receive
Cognitive Behavioral TherapyActive comparatorWeekly Cognitive Behavior therapy
Receives: Behavioral: Cognitive Behavioral Therapy
Wait-listOtherSubjects in wait-list for six-weeks
Receives: Behavioral: Wait-list

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. PG-YBOCS

    Measured: At each visit prior to and after therapy has been completed

Secondary outcomes (1)
  1. Time spent gambling

    Measured: At each visit prior to and after therapy has been completed

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Jun 2006 (estimated)
  2. Study startJun 2006
  3. Primary completionJun 2009
  4. Study completionJun 2009

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 2
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
76 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00337753
Sponsor's protocol ID
0503M68191
Other IDs
K23MH069754-01A1
Status last verified
Jan 2010
First submitted
14 Jun 2006
Last updated
5 Jan 2010
Results posted
No
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

A Phase 2 study testing Cognitive Behavioral Therapy and Wait-list in people with Pathological Gambling, run by University of Minnesota at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 5 Jan 2010. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

PG-YBOCS (time frame: At each visit prior to and after therapy has been completed). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Jan 2010.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in